SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sequenom, Inc. (SQNM)
An SI Board Since January 2000
Posts SubjectMarks Bans Symbol
364 54 0 SQNM
Emcee:  Nav Toor Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
164>> I don't get this one << First, I don't own it. If I havscaram(o)uche-3/3/2004
163Guys, I don't get this one. Where is the catalyst for increased value? Lookeokalani'nui-3/3/2004
162Sheeeeeeeeeeeeesh, that must be fun! Sleuthing. Having a database that's oscaram(o)uche-2/28/2004
161[Whole-genome annotation by using evidence integration in functional-linkage nettuck-2/24/2004
160>>SAN DIEGO, Feb. 10 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (Nasdaq: SQNtuck-2/10/2004
159sequenom.com "...The following is an overview of three targets from each ofnigel bates-1/22/2004
158SEQUENOM Collaborates With Health Protection Agency to Apply MassARRAY(TM) Technnigel bates-1/22/2004
157Teaser from GenomeWeb's SNPTech Report: >>Sequenom Says GAG Bioscienctuck-1/19/2004
156SEQUENOM and LGC Expand Relationship to Include Paternity and Forensic Testing Snigel bates-1/14/2004
155<i>Someone at Sequenom clearly noticed Genaissance's price action on Fnigel bates-1/12/2004
154and <i>disturbing</i>. (eom)scaram(o)uche-12/18/2003
153...and "will retain diagnostic rights". The time lag between the Reutnigel bates-12/18/2003
152yup! SEQUENOM Announces Osteoporosis Collaboration With Procter & Gamble Phscaram(o)uche-12/17/2003
151management is very aggressive, targets are not limiting. we'll need to waitscaram(o)uche-12/17/2003
150Royalties ? OK, so it's not deCode yet, but it's encouraging.nigel bates-12/17/2003
149Sequenom, Procter & Gamble form $30 mln alliance Wednesday December 17, 8:37scaram(o)uche-12/17/2003
148SEQUENOM Announces Gene Expression Agreements With The Institute for Genomic Resnigel bates-12/16/2003
147SEQUENOM Obtains Core Technology Patent in Europe Thursday December 11, 6:30 am nigel bates-12/11/2003
146SEQUENOM Reports Third Quarter 2003 Financial Results SAN DIEGO, Oct. 28 /PRNewnigel bates-10/28/2003
145SEQUENOM Identifies Novel Genetic Risk Markers for Breast Cancer Results Relevannigel bates-10/22/2003
144Revenue forecast - SAN DIEGO, Oct. 6 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (nigel bates-10/7/2003
143SEQUENOM Launches MassARRAY(TM) Compact System; Reference Standard DNA Analysis nigel bates-9/22/2003
142Nuvelo Assigns Patents to SEQUENOM Wednesday September 17, 9:30 am ET SUNNYVALnigel bates-9/17/2003
141SEQUENOM Increases Throughput and Capacity for MassARRAY System SAN DIEGO, Septnigel bates-9/3/2003
140SEQUENOM Announces Genetics Discovery Collaboration With Bristol-Myers Squibb Thnigel bates-7/10/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News